Volume 22, Issue 98 (2-2013)                   J Mazandaran Univ Med Sci 2013, 22(98): 190-198 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saffar M J, Ajami A, Moslemizadeh N, Khalilian A, Saffar H, Shojai J. Pertussis Seroimmunity and One Year Immunogenicity of Combined Adult Type Pertussis Vaccine in Pre marriage Girls, 2009-2011. J Mazandaran Univ Med Sci 2013; 22 (98) :190-198
URL: http://jmums.mazums.ac.ir/article-1-1967-en.html
Abstract:   (14718 Views)
Background and purpose: After marked reduction of pertussis during recent two decades the incidence of disease is increasing, particularly in early infancy. The main sources of infection in this age group are mother and other household close contacts. Our purpose was to examine whether administrating prepregnancy pertussis booster dose can induce long-term protection enough to provide higher maternal antibodies levels to their offsprings compared with prebooster titers. Materials and methods: Totally 114 healthy 18-35 year-old childbearing age women planning to become pregnant were boosted with one dose of adult type pertussis vaccine. Blood samples were obtained before, four weeks, and one year after boosting. Sera were tested for IgG antipertussis-antibodies using ELISA method. Descriptive statistical method and paired t-test were used to compare the data before and after vaccination. Results: Seroprevalence rate and mean concentration of antibodies at before vaccination were 69.3% and 68.19 (SD 38.46) Eu/mL, respectively which significantly increased to 93.8% and 152.82 (SD 70.31) EU/mL, respectively. One year after vaccination these rates were significantly higher than before vaccination (82.4%, and 107.0 (SD44.75) EU/mL, respectively). Serologically recent pertussis infection was detected in 3.5% of the women. Conclusion: Pertussis booster immunization was safe, well tolerated and highly immunogenic and resulted in immunity which was preserved for more than one year. Further investigations with larger sample size and longer duration are recommended. According to these findings and review of literature, targeted prepregnancy pertussis vaccine boosting may be an alternative strategy to protect young infants.
Full-Text [PDF 220 kb]   (2688 Downloads)    

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb